Showing results (201-210 of 361) with videos related to
Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupA Santoro, T Tursz, H Mouridsen, et al.Journal of Virology|June 1, 1992
Alterations of the p53 gene in nasopharyngeal carcinomaP Effert, R McCoy, M Abdel-Hamid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1994
Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancerM Spielmann, T Dorval, F Turpin, et al.International Journal of Cancer|October 15, 1988
Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomasP Busson, G Ganem, P Flores, et al.Molecular Immunology|December 1, 1990
Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reductionY Tagaya, H Wakasugi, H Masutani, et al.Human Gene Therapy|September 15, 2000
Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patientsV Molinier-Frenkel, C Le Boulaire, F A Le Gal, et al.Blood Reviews|December 1, 1994
Treatment of hematological malignancies relapsing after allogeneic bone marrow transplantationJ M Boiron, P Cony-Makhoul, F X Mahon, et al.Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 23, 2010
[Characteristics of transfusion recipients in Bordeaux University Hospital. A descriptive study using hospital claims and haemovigilance system databases]M de Pommerol, V Gilleron, A Kostrzewa, et al.La Nouvelle Presse Medicale|June 10, 1978
[Survey of anthracyclines derivatives in haematology (author's transl)]C Jacquillat, M Weil, M F Auclerc, et al.Bulletin Du Cancer|January 1, 1981
[2 N methyl 9 hydroxy-ellipticine in treatment of metastatic breast cancers (author's transl)]J Rouëssé, D Huertas, H Sancho-Garnier, et al.Pageof 37